Model uncertainty-based evaluation of process strategies during scale-up of biopharmaceutical processes

Johannes Möller,Tanja Hernández Rodríguez,Jan Müller,Lukas Arndt,Kim B. Kuchemüller,Björn Frahm,Regine Eibl,Dieter Eibl,Ralf Pörtner
DOI: https://doi.org/10.1016/j.compchemeng.2019.106693
2020-03-01
Abstract:Reliable scale-up of biopharmaceutical production processes is key in Quality by Design. In this study, a model-based workflow is described to evaluate the bioprocess dynamics during process transfer and scale-up computationally. First, a mathematical model describes the bioprocess dynamics of different state variables (e.g., cell density, titer). Second, the model parameter probability distributions are determined at different scales due to measurement uncertainty. Third, the quantified parameter distributions are statistically compared to evaluate if the process dynamics have been changed. This workflow was tested for the scale-up of an antibody-producing CHO fed-batch process. Significant differences were identified between the process development (30 ml) and implementation (250 ml) scale, and the feeding strategy was validated using model-assisted Design of Experiments. Then, the validated process strategy was successfully scaled up to 2 l laboratory and 50 l pilot scale. In summary, the proposed workflow enables a knowledge-driven evaluation tool for bioprocess development.
engineering, chemical,computer science, interdisciplinary applications
What problem does this paper attempt to address?